Weekly Watchlist and Review 12/3/23

Weekly Watchlist and Review

Welcome aboard the latest of our Weekend Watchlist and Review at ALERTSANDNEWS.COM, where last week’s market was hotter than a ghost pepper in a volcano! There has been some INSANE runners last week. Let’s go through some of our alerts.

The momentum lately could give a cheetah a run for its money. Monday kicked off with BDRX in pre market, hitting targets like a marksman. RDHL followed suit, striking bullseyes left and right. We didn’t stop there; ICCM and HNRA on Tuesday were like target hitting machines. ASST and ESGL smashed targets as well. Wednesday brought the crown jewel: VVOS, skyrocketing a mind-blowing 700%+ from our pre-market alert. Talk about out of this world! The frenzy carried on with stocks splitting faster than a karate master. Thursday? Oh, it was just MINM, SMFL, AGRI, CYTO, and AMPE playing a game of ‘hit the target’. ALT on Friday? Absolutely nailed it. HCDI and VIEW almost smashed targets. And let’s not forget our long term swing plays like INTC and SLG not only paying dividends but also climbing up nicely.

Here at ALERTSANDNEWS.COM, we’re not just accurate; we’re like a GPS for stocks. Covering everything from momentum to dividends and everything in between, we’ve got you covered. But hey, always do your homework. Hunting for first-class alerts and insights? You’re in the right place. Our success stories speak for themselves! And here’s a cherry on top: use code AAN10 for 10% off when you sign up. Ready to skyrocket your trading skills? Sign up today!

Let’s start what to eye tomorrow, and the news over the weekend.

Here’s the Gappers from Friday. ID was the chosen penny. EGOX and WNE strong as well. NEXI bounced a little bit after their massive move and drop after the t-12 halt. 

BTC: Everyone should know that BTC tested 40k over the weekend. Very strong. Means all blockchain plays on watch this week and tomorrow. MARA, RIOT, BTBT, EBON, BITF and others. I’ll have a list ready to go before tomorrow in the room. BTC could test 50k soon. 

Over the weekend, we saw a TON of headlines. Lets take a look at them.

IZEA:IZEA Announces Acquisition of Australian Influencer Marketing Leader Hoozu

FEAM:5E Advanced Materials Announces an Extension to Standstill Agreement

ALK/HA:Alaska Air Set To Acquire Hawaiian Airlines In $1.9B Deal-Alaska Air Group To Acquire Hawaiian Airlines For $18/Share In Cash
 
JNJ: Supreme Court Decision Looms Over Purdue Pharma’s $6B Opioid Settlement And Sackler Family Immunity
 

DASH:New York Food Delivery Workers Win Big Against Uber, DoorDash And GrubHub With $17.96 Minimum Hourly Pay

XENE:Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)

ME: 23andMe Reveals Hackers Accessed ‘Significant Number’ Of DNA Records

MRAI: MARPAI, INC. CONFIRMS IT HAS FILED AN APPEAL TO NASDAQ DELISTING LETTER

  • The Pentagon Said USS Carney And Multiple Commercial Ships Have Come Under Attack In The Red Sea-AP
  • Number 9 container ship is currently sailing. No reports of injuries or pollution after incident in the Red Sea – Manager.
  • German Economy Minister Habeck to remain in Berlin for 2024 budget talks with Germany’s Chancellor Scholz.
  • Pentagon: We’re aware of reports regarding attacks on USS Carney and commercial vessels in the Red Sea.
  • North Korea will take countermeasures against individuals and organisations that impose and enforce sanctions – KCNA.
  • North Korea: We will retaliate against the US, Japan and Australia for sanctions against its satellite launch – KCNA.
  • Iran: Two Revolutionary guards killed in Israeli attack in Syria – State Media.
  • S&PGR affirms France ‘AA/A-1+” ratings; outlook still negative
  • Sam Altman Was Raising A VC Fund When OpenAI Fired Him
  • HAMAS ARMED WING SAYS THEY HAVE BOMBARDED TEL AVIV WITH BARRAGE OF MISSILES

  • 193 PALESTINIANS KILLED, 650 WOUNDED IN GAZA SINCE TRUCE COLLAPSED – GAZA HEALTH MINISTRY SPOKESMAN

 
 

News Coming:

By staying informed about the FDA decisions and other news, investors, healthcare professionals, and patients can gauge the potential impact on the pharmaceutical industry, stock market, and patient care. These decisions can influence the market value of pharmaceutical companies. Let’s look at the news coming: 

Certainly, here is the revised table with the removal of SWTX and TAK, and the addition of BLUE:


Stock TickerCompany NameDecision DetailsEstimated Decision Date
VRTXVertex Pharmaceuticals Inc.FDA decision on Exa-cel for severe sickle cell disease12/08/2023
BCLIBrainstorm Cell Therapeutics Inc

FDA decision on NurOwn for the treatment of amyotrophic lateral sclerosis

UPDATE: The Biologics License Application for NurOwn was withdrawn by the company on Oct.18, 2023

12/08/2023
CRSPCRISPR Therapeutics AGFDA decision on Exa-cel for severe sickle cell disease12/08/2023
MIRMMirum Pharmaceuticals Inc.FDA decision on the expanded use of LIVMARLI in progressive familial intrahepatic cholestasis12/13/2023
TSVT2seventy bio, Inc.

FDA decision on the expanded use of Abecma in triple-class exposed relapsed and refractory multiple myeloma patients, who have received an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.

UPDATE: On Nov.20, 2023, the company announced that an FDA panel is expected to review the sBLA and therefore a decision is unlikely to be made on the assigned PDUFA date

12/16/2023
OPTNOptiNose Inc.FDA decision on the expanded use of XHANCE in treating adults with chronic rhinosinusitis12/16/2023
ARQTArcutis Biotherapeutics Inc.FDA decision on Roflumilast Foam 0.3% for treatment of Seborrheic Dermatitis in Individuals Aged 9 Years and Older12/16/2023
BLUEbluebird bio Inc.FDA decision on Lovo-cel for patients with Sickle Cell Disease 12 years and older with a history of vaso-occlusive events12/20/2023

Let’s look at some oversold and/or highly shorted stocks. 

Grasping the dynamics of oversold and heavily shorted stocks is key for traders and investors looking to capitalize on emerging opportunities. Oversold stocks can be hidden gems, potentially undervalued due to market overreaction. On the other hand, stocks with high short interest are prime candidates for a short squeeze, a situation where a swift price surge happens as short sellers rush to close their positions. Being well-informed about these scenarios equips investors with the insights needed to adeptly maneuver through market fluctuations

SPEC: A recent IPO, is currently navigating through challenging waters. Stoch RSI is in oversold condition, hinting that it might be undervalued after enduring a significant downturn. As it stands, the revival of SPEC largely hinges on an uptick in trading volume. While the short float for this stock isn’t notably high, keeping a close watch on the volume ratios could provide a interesting rebound opportunity. Making SPEC a stock to monitor closely in the upcoming sessions.


LQR: This one is in a tough spot right now, really taking a nosedive. It’s like watching something fall out of the sky, especially after that recent reverse split. And you know, split stocks have been catching some eyes lately. Its Stoch RSI is down in the dumps, totally oversold. With only about 3 million shares floating around, any big moves in volume could really shake things up. Definitely worth keeping an eye on LQR to see if it can pull out of this tailspin.

FSR: FSR’s financials are looking a bit like a bonfire right now, with a cash burn of about $468M over the trailing twelve months. That’s not small change! Despite this, there’s chatter that it might be due for a rebound. It’s been on a steady slide downwards for over a month, so it’s definitely one to watch. I’m adding it to my radar for the next few days and weeks, keeping an eye out for any signs of a bounce back. Could be an interesting play if it turns around.

LAZR: Is looking pretty rough these days. It’s like everyone’s selling and no one’s buying, pushing its RSI way down to the floor. With a hefty float of over 300 million shares, it’s going to need a serious wave of volume to get it moving again. But here’s the kicker… the 50-day SMA is hovering over $3.50. That means there’s potential for a comeback if the buyers start stepping in. I’m keeping an eye on this one; if the volume picks up, we could see some interesting action. Definitely one to watch.

Oversold beat up stocks to eye,

EGRX, VTYX, NVOS, SEEL, CHPT, NNDM, LAC, DOGZ

Earnings Calender:

Economic Calendar and Futures.

Upcoming Economic Events for the Week of December 4th-8th

TIME (ET)REPORTPERIODACTUALMEDIAN FORECASTPREVIOUS
MONDAY, DEC. 4     
10:00 amFactory ordersOct. -3.5%2.8%
TUESDAY, Dec. 5     
9:45 amS&P U.S. services PMINov. 50.850.8
10:00 amISM servicesNov. 52.5%51.8%
10:00 amJob openingsOct. 9.4 million9.6 million
WEDNESDAY, Dec. 6     
8:15 amADP employmentNov. 120,000113,000
8:30 amU.S. productivity (revision)Q3 4.8%4.7%
8:30 amU.S. trade deficitOct. -$64.0B-$61.5B
THURSDAY, Dec. 7     
8:30 amInitial jobless claims12/2 224,000218,000
10:00 amWholesale inventoriesOct. -0.2%0.2%
3:00 pmConsumer creditOct. $8.0B$9.1B
FRIDAY, Dec. 8     
10:00 amConsumer sentiment (prelim)Dec. 62.361.3
8:30 amU.S. employment reportNov.. 190,000150,000
8:30 amU.S. unemployment rateNov. 3.9%3.9%
8:30 amU.S. hourly wagesNov. 0.3%0.2%
8:30 amHourly wages year over year  3.9%4.1%

 

In the first full week of December, a series of economic reports will shed light on the current state and trajectory of the U.S. economy. On Monday, December 4th, factory orders for October are set to be released, with expectations indicating a significant downturn of -3.5%, a stark contrast to the previous month’s increase of 2.8%. Tuesday brings a focus on the services sector with the S&P U.S. Services PMI for November holding steady at 50.8, while the ISM Services Index is expected to show a slight increase to 52.5% from 51.8%. Job openings for October are anticipated to see a slight decrease to 9.4 million, down from 9.6 million.

Midweek, on Wednesday, December 6th, the ADP Employment report for November is expected to reveal a modest rise in private-sector jobs, up to 120,000 from 113,000. Revisions to third-quarter productivity are forecasted at 4.8%, slightly higher than previous estimates. The U.S. trade deficit for October is projected to widen to -$64.0 billion from -$61.5 billion.

Thursday’s focus will be on initial jobless claims for the week ending December 2nd, anticipated to rise slightly to 224,000 from 218,000. October’s wholesale inventories are expected to decrease by -0.2%, contrasting with the previous month’s increase. Consumer credit for October is projected at $8.0 billion, a decrease from $9.1 billion.

The week concludes on Friday, December 8th, with a flurry of reports. Preliminary consumer sentiment for December is expected to edge up to 62.3 from 61.3. The U.S. employment report for November is anticipated to show an addition of 190,000 jobs, a notable increase from the previous 150,000, while the unemployment rate is expected to remain steady at 3.9%. Hourly wages are forecasted to rise modestly in November by 0.3%, with year-over-year wages increasing by 3.9%, slightly lower than the previous 4.1%.

This week’s data will provide a comprehensive look at the various facets of the U.S. economy, offering insights into consumer behavior, labor market trends, and the overall economic health in the closing months of the year.

As of 6:53 PM EDT, market futures are mixed. For more targeted insights and timely alerts, make sure to check us out at alertsandnews.com Don’t forget to use the promo code AAN10 for 10% discount on all our packages. Getting the team the first mover advantage. Get informed first with your command center for the markets. Don’t let the next big opportunity pass you by! Join the team today!

DISCLAIMER

The forum, blog, watchlist and chatrooms on the Site are comprised of customers and members (including, without limitation, moderators who are in the employ of Alerts and News) posting content and information. All such information and content is for informational purposes only and does not constitute advice or a recommendation by Alerts and News to enter into any securities transactions or engage in any of the financial strategies reflected on or suggested in forum, blog, watchlist and chatrooms (whether such data, content or information is posted by Alerts and News or otherwise). Customers and members may write about securities in which they have a financial or other interest, and performance data reflecting other customer’s or member’s holdings may include information about securities not held by Alerts and News or its directors, officers, shareholders, employees, agents or affiliates. As such, Alerts and News is not responsible for the accuracy of data, content or information or any performance data in any forum, blog, watchlist and chatrooms; and the accuracy of data, content or information or any performance data are not guaranteed, may not be current and should not be relied upon. Nothing in any forum, blog, watchlist and chatrooms is intended as, nor should you rely on it as, investment advice provided by Alerts and News or its directors, officers, shareholders, employees, agents or affiliates. AlertsAndNews receives cash compensation for referring potential clients to Benzinga LLC via advertisements placed on their website. AlertsAndNews’s opinions are their own.

Take your trading to the next step!

Try a trial – for less than a cup of coffee

Shopping Cart
Scroll to Top